Overview

Micronized dHACM Injectable for the Treatment of Plantar Fasciitis

Status:
Active, not recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
Prospective, double-blinded, randomized controlled trial of the micronized dHACM injection as compared to the saline placebo injection in the treatment of plantar fasciitis
Phase:
Phase 3
Details
Lead Sponsor:
MiMedx Group, Inc.